• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by HealthEquity Inc.

    3/27/26 9:34:22 AM ET
    $HQY
    Real Estate
    Real Estate
    Get the next $HQY alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 9)


    HealthEquity Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    42226A107

    (CUSIP Number)
    03/13/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    42226A107


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    IA

    Comment for Type of Reporting Person:   On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    HealthEquity Inc
    (b)Address of issuer's principal executive offices:

    15 West Scenic Pointe Drive, Suite 100, Draper, UT, 84020
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd.,, Malvern, PA, 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    0
    (b)Percent of class:

    0  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:03/27/2026
    Get the next $HQY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HQY

    DatePrice TargetRatingAnalyst
    1/9/2026$89.00Neutral → Sell
    Goldman
    12/9/2025$118.00Overweight
    Barclays
    11/13/2025$100.00Market Perform
    BMO Capital Markets
    5/22/2025$105.00 → $112.00Outperform
    RBC Capital Mkts
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    12/4/2024$126.00Outperform
    Mizuho
    11/15/2024$108.00Neutral
    Goldman
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $HQY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HealthEquity downgraded by Goldman with a new price target

    Goldman downgraded HealthEquity from Neutral to Sell and set a new price target of $89.00

    1/9/26 8:49:40 AM ET
    $HQY
    Real Estate

    Barclays initiated coverage on HealthEquity with a new price target

    Barclays initiated coverage of HealthEquity with a rating of Overweight and set a new price target of $118.00

    12/9/25 8:49:54 AM ET
    $HQY
    Real Estate

    BMO Capital Markets initiated coverage on HealthEquity with a new price target

    BMO Capital Markets initiated coverage of HealthEquity with a rating of Market Perform and set a new price target of $100.00

    11/13/25 9:13:59 AM ET
    $HQY
    Real Estate

    $HQY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

    Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion.Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.Net income per diluted share rose to $2.46 from $1.09 one year ago, and non-GAAP net income per diluted share increased 28% to $4.00.Adjusted EBITDA increased 20% to $566.0 million, and Adjusted EBITDA margin increased to 43% from 39% last year.Total HSA Assets grew 14% to $36.5 billion.Returned $301.7 million to shareholders through stock repurchases.Further reduced HSA cash repricing risk with a cumulative $2.35 billion 5-year Treasury bond hedge at 3.92%. Highlights of the fourth quarter include: Revenue incre

    3/17/26 4:01:00 PM ET
    $HQY
    Real Estate

    Phreesia Appoints Jon Kessler to Board of Directors

    Industry Veteran Brings Track Record of Technology-Driven Growth and Value Creation Edward L. Cahill and Michael Weintraub to Retire at 2026 Annual Meeting of Stockholders Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") today announced that it has appointed Jon Kessler to its Board, effective April 6, 2026. In addition, Edward L. Cahill and Michael Weintraub have informed the Board that they will retire from the Board, effective at the 2026 Annual Meeting. Mr. Kessler is an experienced public company CEO and director who will bring valuable expertise to the Phreesia Board. As founder, Chairman and CEO of WageWorks and most recently President and CEO of HealthEquity (NASDAQ:HQY

    2/23/26 4:03:00 PM ET
    $HQY
    $PHR
    Real Estate

    HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

    DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian by number of accounts and leading provider of complementary consumer-directed benefits ("CDBs"), today announced its HSAs, HSA Assets, and Total Accounts as of its fiscal year ended January 31, 2026. The Company also reaffirmed its guidance for fiscal 2026 and 2027, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2026 was 10.6 million, an increase of 7% from 9.9 million as of January 31, 2025. The Company closed fiscal year

    2/17/26 4:00:00 PM ET
    $HQY
    Real Estate

    $HQY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parker Stuart B. was granted 1,263 shares, increasing direct ownership by 6% to 23,098 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    2/4/26 1:06:09 PM ET
    $HQY
    Real Estate

    Director Natarajan Rajesh was granted 976 shares, increasing direct ownership by 7% to 15,253 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    2/4/26 1:01:53 PM ET
    $HQY
    Real Estate

    President and CEO Cutler Scott covered exercise/tax liability with 12,496 shares, decreasing direct ownership by 10% to 109,820 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    1/14/26 4:18:23 PM ET
    $HQY
    Real Estate

    $HQY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by HealthEquity Inc.

    SCHEDULE 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    3/27/26 9:34:22 AM ET
    $HQY
    Real Estate

    SEC Form 10-K filed by HealthEquity Inc.

    10-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    3/17/26 4:03:59 PM ET
    $HQY
    Real Estate

    HealthEquity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    3/17/26 4:02:34 PM ET
    $HQY
    Real Estate

    $HQY
    Leadership Updates

    Live Leadership Updates

    View All

    HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation

    DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced the appointment of new senior executives to accelerate the company's strategic vision and capitalize on expanding market opportunities. Mukund Ramachandran joins as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management, effective September 29, 2025. The appointments come as HealthEquity continues to execute against record financial performance, alongside the largest HSA eligibility expansion in 20 years following recent federal legislation.

    9/25/25 9:00:00 AM ET
    $HQY
    Real Estate

    HealthEquity Reports Year-End Sales Metrics

    DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,

    2/18/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference

    DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth. Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier.Estimated HSA Assets to be approximately $31 billion, up from $25.2 billion at the end of fiscal year 2024, with approximately $17 billion of HSA Cash. Invested balances included in the estimated assets a

    1/13/25 9:01:00 AM ET
    $HQY
    Real Estate

    $HQY
    Financials

    Live finance-specific insights

    View All

    HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

    Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion.Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.Net income per diluted share rose to $2.46 from $1.09 one year ago, and non-GAAP net income per diluted share increased 28% to $4.00.Adjusted EBITDA increased 20% to $566.0 million, and Adjusted EBITDA margin increased to 43% from 39% last year.Total HSA Assets grew 14% to $36.5 billion.Returned $301.7 million to shareholders through stock repurchases.Further reduced HSA cash repricing risk with a cumulative $2.35 billion 5-year Treasury bond hedge at 3.92%. Highlights of the fourth quarter include: Revenue incre

    3/17/26 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

    Highlights of the third quarter include: Revenue increased 7% to $322.2 million.Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01.Total HSA Assets grew 15% to $34.4 billion.Returned $93.7 million to shareholders through stock repurchases.Further reduced HSA cash repricing risk with a cumulative $2.25 billion 5-year Treasury bond hedge at 3.94%. DRAPER, Utah, Dec. 03, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), a leader in administering health savings accounts ("HSAs") and complementary consumer-directed benefits ("CDBs"), today announced financial results for

    12/3/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces Third Quarter Earnings Date

    DRAPER, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest Health Savings Accounts ("HSA") and consumer-directed benefits administrator, today announced plans to release financial results of its third quarter of fiscal 2026 following the close of regular stock market trading hours on Wednesday, December 3, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Wednesday, December 3, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results. HealthEquity Third Quarter Fiscal Year 2026 Results Conference CallDate: December

    11/5/25 4:01:00 PM ET
    $HQY
    Real Estate

    $HQY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/13/24 5:06:19 PM ET
    $HQY
    Real Estate

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/9/24 4:15:05 PM ET
    $HQY
    Real Estate

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/9/24 9:16:06 AM ET
    $HQY
    Real Estate